全文获取类型
收费全文 | 3310篇 |
免费 | 215篇 |
国内免费 | 6篇 |
学科分类
医药卫生 | 3531篇 |
出版年
2023年 | 36篇 |
2022年 | 54篇 |
2021年 | 137篇 |
2020年 | 50篇 |
2019年 | 122篇 |
2018年 | 134篇 |
2017年 | 94篇 |
2016年 | 100篇 |
2015年 | 85篇 |
2014年 | 138篇 |
2013年 | 185篇 |
2012年 | 263篇 |
2011年 | 231篇 |
2010年 | 131篇 |
2009年 | 118篇 |
2008年 | 197篇 |
2007年 | 186篇 |
2006年 | 197篇 |
2005年 | 188篇 |
2004年 | 165篇 |
2003年 | 121篇 |
2002年 | 120篇 |
2001年 | 29篇 |
2000年 | 35篇 |
1999年 | 16篇 |
1998年 | 29篇 |
1997年 | 18篇 |
1996年 | 20篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 24篇 |
1992年 | 10篇 |
1991年 | 25篇 |
1990年 | 18篇 |
1989年 | 13篇 |
1988年 | 18篇 |
1987年 | 16篇 |
1986年 | 23篇 |
1985年 | 13篇 |
1983年 | 14篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1976年 | 8篇 |
1975年 | 10篇 |
1974年 | 13篇 |
1971年 | 6篇 |
1967年 | 11篇 |
排序方式: 共有3531条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
Vitamin D Analogue: Potent Antiproliferative Effects on Cancer Cell Lines and Lack of Hypercalcemic Activity 下载免费PDF全文
75.
Amirahmadi Roxana Sullivan Scott Britton Noel Siegel Ariel Spiegel Rory Miceli Jennifer Duong Vu Sholander Jeffrey T. Fontaine Magali J. McCurdy Michael T. 《Annals of hematology》2022,101(9):2045-2052
Annals of Hematology - Despite the low risk of peripherally inserted central catheter (PICC) insertion-related bleeding, the practice of administering prophylactic platelets varies greatly.... 相似文献
76.
Folayan Morenike Oluwatoyin Ibigbami Olanrewaju Brown Brandon El Tantawi Maha Uzochukwu Benjamin Ezechi Oliver C. Aly Nourhan M. Abeldaño Giuliana Florencia Ara Eshrat Ayanore Martin Amogre Ayoola Oluwagbemiga O. Osamika Bamidele Emmanuel Ellakany Passent Gaffar Balgis Idigbe Ifeoma Ishabiyi Anthonia Omotola Jafer Mohammed Khan Abeedha Tu-Allah Khalid Zumama Lawal Folake Barakat Lusher Joanne Nzimande Ntombifuthi P. Popoola Bamidele Olubukola Quadri Mir Faeq Ali Rashwan Maher Roque Mark Shamala Anas Al-Tammemi Ala’a B. Yousaf Muhammad Abrar Abeldaño Zuñiga Roberto Ariel Okeibunor Joseph Chukwudi Nguyen Annie Lu 《AIDS and behavior》2022,26(3):739-751
AIDS and Behavior - The aim of the study was to assess if there were significant differences in the adoption of COVID-19 risk preventive behaviors and experience of food insecurity by people living... 相似文献
77.
78.
Oren Zusman Gregg S. Pressman Shmuel Banai Ariel Finkelstein Yan Topilsky 《JACC: Cardiovascular Imaging》2018,11(9):1225-1232
Objectives
The purpose of this study was to describe patients with severe symptomatic aortic stenosis with normal flow and low gradients and determine whether they benefit from intervention.Background
Severe symptomatic aortic stenosis is a progressive disease with high mortality. Although surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR) are indicated for patients with high gradients (>40 mm Hg) or low gradients due to low flow, the approach for patients with normal flow and low gradients is poorly defined.Methods
Consecutive adult patients who underwent echocardiography between 2012 and 2015 at Tel-Aviv Medical Center and had an aortic valve area of ≤1.0 cm2, a mean gradient of <40 mm Hg, a stroke volume index of >35 ml/m2, and symptoms formed the study group. Patients designated for intervention (SAVR or TAVR) had their procedure within 6 months of the echocardiogram; the others were treated conservatively. The endpoints were all-cause mortality and cardiac-related mortality.Results
During the study period, 1,358 patients with an aortic valve area of ≤1.0 cm2 and symptoms were identified; 34% of these had normal flow and low gradient aortic stenosis and 303 were included. After mean follow-up of 652 days, 60 patients (20%) had died, with overall mortality rates of 28%, 10%, and 12% for conservatively treated, TAVR, and SAVR patients, respectively (p < 0.001). Using Cox regression with adjustment for other variables, TAVR was associated with improved survival versus conservative treatment (hazard ratio [HR]: 0.49; 95% confidence interval [CI]: 0.26 to 0.93; p = 0.03), and lower cardiac mortality (HR: 0.30; 95% CI: 0.10 to 0.74; p = 0.007) with no significant difference for SAVR versus TAVR. After propensity score matching of TAVR and conservatively treated patients, 25 of 94 (28%) conservatively treated and 10 of 94 (12%) TAVR patients had died (p = 0.016). In the matched cohort, Cox regression showed that TAVR had a significant association with improved survival (HR: 0.42; 95% CI: 0.20 to 0.86; p = 0.03).Conclusions
Symptomatic patients with an aortic valve area of ≤1.0 cm2, normal flow, and low gradient may benefit from intervention as opposed to conservative treatment. 相似文献79.
Ghrelin secretion in humans is sexually dimorphic,suppressed by somatostatin,and not affected by the ambient growth hormone levels 总被引:11,自引:0,他引:11
Barkan AL Dimaraki EV Jessup SK Symons KV Ermolenko M Jaffe CA 《The Journal of clinical endocrinology and metabolism》2003,88(5):2180-2184
We studied plasma ghrelin and GH concentrations over a 24-h period in young healthy men and women and in patients with acromegaly. Healthy subjects were restudied after administration of GH-lowering agents, octreotide or GHRH antagonist. Ghrelin concentrations in women studied during the late follicular stage of the cycle were about 3-fold higher than in men. Suppression of GH secretion by GHRH antagonist did not alter ghrelin concentration profiles. In the presence of high GH levels (acromegaly), ghrelin levels were similar to those found in healthy men. Administration of somatostatin analog octreotide suppressed both GH and ghrelin concentration profiles. We conclude that: 1) ghrelin secretion is sexually dimorphic in humans, with women in the late follicular stage having higher levels than men; 2) ghrelin secretion is suppressed by somatostatin; and 3) GH has no influence over ghrelin secretion. 相似文献
80.
Ofer Beharier Romina Plitman Mayo Tal Raz Kira Nahum Sacks Letizia Schreiber Yael Suissa-Cohen Rony Chen Rachel Gomez-Tolub Eran Hadar Rinat Gabbay-Benziv Yuval Jaffe Moshkovich Tal Biron-Shental Gil Shechter-Maor Sivan Farladansky-Gershnabel Hen Yitzhak Sela Hedi Benyamini-Raischer Nitzan D. Sela Debra Goldman-Wohl Ziv Shulman Ariel Many Haim Barr Simcha Yagel Michal Neeman Michal Kovo 《The Journal of clinical investigation》2021,131(13)
BACKGROUNDThe significant risks posed to mothers and fetuses by COVID-19 in pregnancy have sparked a worldwide debate surrounding the pros and cons of antenatal SARS-CoV-2 inoculation, as we lack sufficient evidence regarding vaccine effectiveness in pregnant women and their offspring. We aimed to provide substantial evidence for the effect of the BNT162b2 mRNA vaccine versus native infection on maternal humoral, as well as transplacentally acquired fetal immune response, potentially providing newborn protection.METHODSA multicenter study where parturients presenting for delivery were recruited at 8 medical centers across Israel and assigned to 3 study groups: vaccinated (n = 86); PCR-confirmed SARS-CoV-2 infected during pregnancy (n = 65), and unvaccinated noninfected controls (n = 62). Maternal and fetal blood samples were collected from parturients prior to delivery and from the umbilical cord following delivery, respectively. Sera IgG and IgM titers were measured using the Milliplex MAP SARS-CoV-2 Antigen Panel (for S1, S2, RBD, and N).RESULTSThe BNT162b2 mRNA vaccine elicits strong maternal humoral IgG response (anti-S and RBD) that crosses the placenta barrier and approaches maternal titers in the fetus within 15 days following the first dose. Maternal to neonatal anti-COVID-19 antibodies ratio did not differ when comparing sensitization (vaccine vs. infection). IgG transfer ratio at birth was significantly lower for third-trimester as compared with second trimester infection. Lastly, fetal IgM response was detected in 5 neonates, all in the infected group.CONCLUSIONAntenatal BNT162b2 mRNA vaccination induces a robust maternal humoral response that effectively transfers to the fetus, supporting the role of vaccination during pregnancy.FUNDINGIsrael Science Foundation and the Weizmann Institute Fondazione Henry Krenter. 相似文献